BioCardia, Inc.
BCDA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000925741
In the last 90 days, BioCardia, Inc. insiders filed 9 open-market purchases and 0 sales; 21 institutions reported holding it in 13F filings for Q2 2026, worth $1.65M in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in BioCardia, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- +2 vs. Q2 2021
- Shares held
- 2.87M
- −228.7K (−7.4%) vs. Q2 2021
- Total value
- $9.01M
- −$3.29M (−26.7%) vs. Q2 2021
- New holders
- 6
- 2 more added
- Sold out
- 4
- 6 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BCDA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 21 | $1.65M |
| Q1 2026 | 18 | $831.1K |
| Q4 2025 | 20 | $812.3K |
| Q3 2025 | 18 | $551.9K |
| Q2 2025 | 16 | $593.2K |
| Q1 2025 | 12 | $623.8K |
| Q4 2024 | 13 | $272.2K |
| Q3 2024 | 9 | $316.6K |
| Q2 2024 | 10 | $227.8K |
| Q1 2024 | 22 | $790.8K |
| Q4 2023 | 24 | $1.37M |
| Q3 2023 | 16 | $709.6K |
| Q2 2023 | 23 | $4.43M |
| Q1 2023 | 23 | $4.09M |
| Q4 2022 | 25 | $4.87M |
| Q3 2022 | 23 | $3.17M |
| Q2 2022 | 26 | $3.10M |
| Q1 2022 | 24 | $5.49M |
| Q4 2021 | 23 | $5.78M |
| Q3 2021 | 22 | $9.01M |
| Q2 2021 | 20 | $12.3M |
| Q1 2021 | 19 | $13.5M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding BioCardia, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 69 | $0 | 0.00% | −16−18.8% | Reduced |
| Morgan Stanley | 1,383 | $4.00K | 0.00% | 00.0% | Unchanged |
| US Bancorp | 3,612 | $11.0K | 0.00% | +3,612 | New |
| Simplex Trading, LLC | 4,371 | $17.0K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 6,359 | $20.0K | 0.00% | +624+10.9% | Added |
| Millennium Management LLC | 10,015 | $31.0K | 0.00% | +10,015 | New |
| Bank of New York Mellon Corp | 12,854 | $40.0K | 0.00% | 00.0% | Unchanged |
| Commonwealth Equity Services, LLC | 16,492 | $51.0K | 0.00% | +16,492 | New |
| Northern Trust Corp | 19,226 | $60.0K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 19,284 | $61.0K | 0.00% | −12,089−38.5% | Reduced |
| State Street Corp | 21,000 | $66.0K | 0.00% | +21,000 | New |
| Brown Advisory Inc | 33,085 | $104.0K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 35,179 | $110.0K | 0.00% | −748−2.1% | Reduced |
| Advisor Group Holdings, Inc. | 39,257 | $124.0K | 0.00% | −3,612−8.4% | Reduced |
| Renaissance Technologies LLC | 43,549 | $137.0K | 0.00% | −58,681−57.4% | Reduced |
| Susquehanna International Group, LLP | 43,797 | $138.0K | 0.00% | +43,797 | New |
| Geode Capital Management, LLC | 76,825 | $241.0K | 0.00% | 00.0% | Unchanged |
| Family Management Corp | 142,186 | $446.0K | 0.12% | +142,186 | New |
| CM Management, LLC | 329,000 | $1.03M | 0.77% | 00.0% | Unchanged |
| Vanguard Group Inc | 411,969 | $1.29M | 0.00% | 00.0% | Unchanged |
| Captrust Financial Advisors | 660,637 | $2.07M | 0.02% | +1,274+0.2% | Added |
| Roumell Asset Management, LLC | 938,380 | $2.95M | 3.90% | −318,823−25.4% | Reduced |
| Virtu Financial LLC | 0 | $0 | 0.00% | −33,264−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −21,680−100.0% | Sold out |
| Magnus Financial Group LLC | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −3,750−100.0% | Sold out |